 The purpose of this study was to assess the efficacy and tolerability of changing to DUOTRAV from prior bimatoprost 0.03timolol 0.5 pharmacotherapy in subjects with open-angle glaucoma or ocular hypertension having uncontrolled intraocular pressure IOP. 